|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 901.2 USD | +0.79% |
|
-3.74% | +2.61% |
| Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
| Apr. 17 | The market is pinning its hopes on earnings reports |  |
In "The Butcher's Son Seeking a Drug That Can Cut Down Coronavirus," at 9:17 a.m. ET, the last name of Regeneron Chief Scientific Officer George Yancopoulos was misspelled. (Corrected on June 26)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.61% | 96.09B | |
| -3.39% | 102B | |
| -1.02% | 22.05B | |
| -18.14% | 20.81B | |
| -6.87% | 19.06B | |
| -40.70% | 16.05B | |
| -26.89% | 14.01B | |
| +1.12% | 13.38B | |
| +22.25% | 11.01B | |
| -18.85% | 9.12B |
REGENERON PHARMACEUTICALS, INC. 
